Series
Kobayashi M．Value-based Approach [Special edition] Simulate the infection situation of new coronavirus. A thorough description of the number of reproduction and sensitive analysis! Monthly Medical Information Express. 2020; 7:36-41. (in Japanese)
Kobayashi M．Value-based Approach [30] Introduction to analysis guideline(9) Modeling①The model has the essence of HTA for Japan! The person controlling a model wins HTA for Japan! Monthly Medical Information Express. 2020; 6:78-80. (in Japanese)
Kobayashi M．Value-based Approach [29] Introduction to analysis guideline(8) Effect indicator③Problem of the QOL Value evaluation The most important QOL Value evaluation in HTA for Japan. Monthly Medical Information Express. 2020; 5:76-78. (in Japanese)
Kobayashi M．Value-based Approach [28] Introduction to analysis guideline(7) Effect indicator②QOL Value Learn the investigation method of QOL value calculation. Monthly Medical Information Express. 2020; 3:78-80. (in Japanese)
Kobayashi M. Value-based Approach [27]. Introduction to analysis guideline(6) Effect indicator① Thorough explanation of QALY Objectively evaluate medical value. Monthly Medical Information Express. 2020; 2:78-81.(in Japanese)
Kobayashi M. Value-based Approach [26]. Introduction to analysis guideline(5) The additional benefit② A benefit of medical fee calculation resembles cost-effectiveness evaluation and non-becomes. Monthly Medical Information Express. 2020; 1:78-81.(in Japanese)
Kobayashi M. Value-based Approach [25]. Introduction to analysis guideline(4) The additional benefit A benefit of medical fee calculation resembles cost-effectiveness evaluation and non-becomes. Monthly Medical Information Express. 2019; 11:78-81.(in Japanese)
Kobayashi M. Value-based Approach [24]. Introduction to analysis guideline(3) Analysis target group and Comparative technology Corporate strategy and the ability of negotiations tried by comparative setting. Monthly Medical Information Express. 2019; 10:78-81. (in Japanese)
Kobayashi M. Value-based Approach [23]. Introduction to analysis guideline(2) The position and cost of analysis. The significance indicating “public medical treatment”. Monthly Medical Information Express. 2019; 9:70-73. (in Japanese)
Kobayashi M. Value-based Approach [22]. Introduction to analysis guideline(1) Full-scale introduction of cost-effectiveness evaluation A thorough description of analysis guideline. Monthly Medical Information Express. 2019; 8:66-69. (in Japanese)
